Skip to main content
SpringerLink
Log in

Marcatori genetici di aggressività nel carcinoma papillare della tiroide (PTC)

  • GENETICA IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Coco D, Pizzimenti C, Militi G et al. (2022) Diagnosi istologica delle varianti aggressive del carcinoma papillare tiroideo. Endocrinologo. https://doi.org/10.1007/s40619-021-01006-z

    Article  Google Scholar 

  2. Vigneri R, Malandrino P, Russo M (2020) Is thyroid cancer increasing in incidence and aggressiveness? J Clin Endocrinol Metab 105(7):dgaa223

    Article  PubMed  Google Scholar 

  3. Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322

    Article  PubMed  Google Scholar 

  4. Cappola AR, Mandel SJ (2013) Molecular testing in thyroid cancer: BRAF mutation status and mortality. JAMA 309:1529–1530

    Article  CAS  PubMed  Google Scholar 

  5. Haq M, Harmer C (2005) Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 63:87–93

    Article  CAS  Google Scholar 

  6. Wang Z, Chen JQ, Liu JL, Qin XG (2016) Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. J Clin Invest 46(2):146–157

    CAS  Google Scholar 

  7. Gandolfi G, Sancisi V, Piana S, Ciarrocchi A (2015) Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma. Int J Cancer 137(5):1001–1011

    Article  CAS  PubMed  Google Scholar 

  8. Sancisi V, Nicoli D, Ragazzi M et al. (2012) A.BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas. J Clin Endocrinol Metab 97(9):E1745

    Article  CAS  PubMed  Google Scholar 

  9. Weinrich SL, Pruzan R, Ma L et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17(4):498–502

    Article  CAS  PubMed  Google Scholar 

  10. Vinagre J, Almeida A, Populo H et al. (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4:2185

    Article  PubMed  Google Scholar 

  11. Melo M, da Rocha AG, Vinagre J et al. (2014) TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 99:E754

    Article  CAS  PubMed  Google Scholar 

  12. Gandolfi G, Ragazzi M, Frasoldati A et al. (2015) TERT promoter mutations are associated with distant metastases in Papillary Thyroid Carcinoma. Eur J Endocrinol 172(4):403–413

    Article  CAS  PubMed  Google Scholar 

  13. Yang J, Gong Y, Yan S et al. (2020) Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis. Endocrine 67(1):44–57

    Article  CAS  PubMed  Google Scholar 

  14. Panebianco F, Nikitski AV, Nikiforova MN et al. (2019) Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer. Cancer Med 8:5831–5839

    Article  CAS  PubMed  Google Scholar 

  15. Liu R, Xing M (2016) TERT promoter mutations in thyroid cancer. Endocr-Relat Cancer 23(3):R143–155

    Article  CAS  PubMed  Google Scholar 

  16. Gandolfi G, Ragazzi M, de Biase D et al. (2017) Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas. Oncotarget 9(2):1813–1825

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratorio di Ricerca Traslazionale, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italia

    Benedetta Donati, Federica Torricelli & Alessia Ciarrocchi

Authors
  1. Benedetta Donati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Federica Torricelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessia Ciarrocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessia Ciarrocchi.

Ethics declarations

Conflitto di interesse

Le autrici Benedetta Donati, Federica Torricelli e Alessia Ciarrocchi dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Le autrici di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da Vito Guarnieri.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donati, B., Torricelli, F. & Ciarrocchi, A. Marcatori genetici di aggressività nel carcinoma papillare della tiroide (PTC). L'Endocrinologo 23, 314–316 (2022). https://doi.org/10.1007/s40619-022-01071-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-022-01071-y

Search

Navigation